Takeda presents real-world evidence at ash 2020, demonstrating its long-standing commitment to personalizing treatments for rare bleeding disorders

Cambridge, mass. & osaka, japan--(business wire)--takeda today presented five hematology poster presentations and four abstracts at the 62nd american society of hematology (ash) annual meeting.

TAK Ratings Summary

TAK Quant Ranking